Search All News
Age-related memory loss is caused, in part, by lack of flavanols—nutrients found in certain fruits and vegetables—according to a large study in older adults.
Taking a daily multivitamin may help slow age-related memory decline, a study has found.
Columbia is leading the movement to add neurocognitive screening to annual well woman OB/GYN checkups.
Though limited to patients with a rare genetic mutation, the newest drug for ALS could be most effective when given before symptoms emerge.
- March 20, 2019
Survivors of cardiac arrest are more likely to experience further heart trouble if they have symptoms of PTSD, according to a new study from researchers at Columbia University Irving Medical Center.
- February 8, 2019
A hormone called irisin–produced during exercise–may protect neurons against Alzheimer’s disease.
- January 31, 2019
Aerobic exercise is known to improve cognition in the elderly; a new Columbia study shows it’s good for adults as young as 20.
- January 22, 2019
A new study by Columbia researchers suggests aspirin may lower stroke risk among middle-aged women with a history of preeclampsia.
- December 28, 2018
Columbia neurologists and engineers are developing what would be the first wearable diagnostic device for traumatic brain injury.
- December 17, 2018
A new study shows how cellular “housekeeping” protects some neurons against the toxic proteins of Alzheimer’s disease and suggests new treatment possibilities.
- November 28, 2018
Increasingly, transformative therapies are being launched via startups emerging from university research labs, including those at Columbia’s Vagelos College of Physicians and Surgeons.
- November 26, 2018
Scientists initially believed Alzheimer's would be a simple, straightforward problem to solve, but now Columbia researchers are looking for unusual and untried solutions.
- November 19, 2018
A new program at Columbia is looking for earlier signs of ALS so that future treatments can be delivered before extensive neurological damage occurs.
- September 26, 2018
Columbia neurologists found that a test used to measure Alzheimer's disease proteins in spinal fluid can be used to determine whether patients have the disease or other forms of dementia.